| Trial Identifier: | D7332R00002 |
| Sponsor: | AstraZeneca |
| Start Date: | April 2026 |
| Primary Completion Date: | June 2028 |
| Study Completion Date: | June 2028 |
| Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| South Korea | Busan, South Korea |
| South Korea | Daegu, South Korea |
| South Korea | Hwasun-gun, South Korea |
| South Korea | Seoul, South Korea |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company